BRIEF

on AlayaCare

Enliven Home Infusion Specialists Achieves 200% Revenue Growth with AlayaCare Technology

Enliven Home Infusion Specialists, a leading infusion nursing agency, has witnessed a 200% increase in revenue after adopting AlayaCare's home-based care technology. The transition from traditional paper-based systems has also led to a 40% reduction in billing time, enhancing overall operational efficiency. This shift was motivated by Enliven's need to manage an expanding patient base and the complexities of partner pharmacies efficiently.

The integration of AlayaCare's platform has streamlined administrative processes, allowing for real-time documentation and quicker invoicing. This has significantly reduced billing processing time by 40%. The technology has enabled nurses to complete paperwork electronically on the day of the infusion, thereby optimizing workflows and saving time. Furthermore, the adoption of AlayaCare's solutions has improved scheduling efficiency and reduced commute times for nurses, leading to higher retention rates.

Enliven's CEO, Ray Landingin, highlights the benefits of the new system, stating that the custom dashboards and reports have provided greater visibility into operations, facilitating expansion into multiple service locations. Since partnering with AlayaCare in 2020, Enliven has tripled its operational states, doubled its field staff, and almost doubled its specialty pharmacy partners.

Rhonda Bosch, Senior Vice President of Customer Success at AlayaCare, expressed pride in partnering with Enliven, emphasizing that the tailored solutions have empowered Enliven to expand their services and drive innovation in home infusion care. This partnership stands as a testament to the transformative potential of technology in enhancing patient care and operational efficiency in the home infusion sector.

R. E.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved. Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all AlayaCare news